Davita Inc vs iShares iBoxx $ High Yield Corporate Bond ETF — how do they compare? Davita Inc trades at $178.34 (market cap $11.72B), while iShares iBoxx $ High Yield Corporate Bond ETF trades at $79.53. The key difference: Davita Inc is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| DVA | HYG | |
|---|---|---|
Market Cap | $11.72B | — |
Sector | Health | Fixed Income |
52-Week High | $240.96 | $81.32 |
52-Week Low | $103.87 | $78.72 |
Enterprise Value | $24.44B | — |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
HYG trades at $79.61, up 0.19% on the day, with a bullish technical signal driven by oscillators despite bearish moving averages. Recent dividends include $0.41 paid in June 2026. News highlights bond market volatility amid oil price swings and inflation data anticipation, with HYG noted for its high-yield corporate bond exposure and liquidity as the largest junk bond ETF.
Outlook hinges on interest rate trends and economic stability, offering income through dividends but facing risks from rising yields and credit spreads. Investors should weigh HYG's role in diversified portfolios against potential downside from macroeconomic shifts.
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →